Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Gene Therapy

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...

Gene Therapy

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The German National Strategy for Gene- and Cell-Based Therapies: Generating Impact by Employing a Novel Multi-Stakeholder Approach.

Human gene therapy·2026

Same author

From Idea to Data: An Agentic Architecture for the Clinical Trial Life Cycle.

Studies in health technology and informatics·2026

Same author

LLM-Assisted Clinical Data Harmonization: Combining Automated ETL Generation with Semantic Vocabulary Mapping for OMOP CDM.

Studies in health technology and informatics·2026

Same author

Interpretable Feature Extraction from Clinical Notes for Sepsis Prediction: Comparing Rule-Based, LLM, and Hybrid Approaches.

Studies in health technology and informatics·2026

Same author

OMOP Extraction of Medical Text Using LLMs: Preliminary Results.

Studies in health technology and informatics·2026

Same author

Bridging Theory and Practice: A Matrix-Based Approach to Teaching Medical Data Science with MIMIC-IV Demo Dataset.

Studies in health technology and informatics·2026

Search research articles

Related Experiment Video

Updated: May 10, 2026

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells

Published on: February 15, 2019

A largely random AAV integration profile after LPLD gene therapy.

Christine Kaeppel¹, Stuart G Beattie, Raffaele Fronza

¹National Center for Tumor Diseases and German Cancer Research Center, Heidelberg, Germany.

Nature Medicine

|June 18, 2013

Summary

Adeno-associated virus (AAV) integration into host DNA is a safety concern. This study found random nuclear and mitochondrial DNA integration, suggesting AAV integration may be safe for gene therapy.

More Related Videos

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus (AAV) Capsid Variants

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus (AAV) Capsid Variants

Published on: October 18, 2022

Engineering and Evolution of Synthetic Adeno-Associated Virus (AAV) Gene Therapy Vectors via DNA Family Shuffling

Engineering and Evolution of Synthetic Adeno-Associated Virus (AAV) Gene Therapy Vectors via DNA Family Shuffling

Published on: April 2, 2012

Related Experiment Videos

Last Updated: May 10, 2026

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells

Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells

Published on: February 15, 2019

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus (AAV) Capsid Variants

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus (AAV) Capsid Variants

Published on: October 18, 2022

Engineering and Evolution of Synthetic Adeno-Associated Virus (AAV) Gene Therapy Vectors via DNA Family Shuffling

Engineering and Evolution of Synthetic Adeno-Associated Virus (AAV) Gene Therapy Vectors via DNA Family Shuffling

Published on: April 2, 2012

Area of Science:

Molecular Biology
Gene Therapy
Virology

Background:

Clinical use of adeno-associated virus vectors (AAVs) is restricted due to potential AAV integration-mediated tumorigenicity.
Understanding AAV integration patterns is crucial for assessing its safety in gene therapy applications.

Purpose of the Study:

To investigate the integration sites of AAV vectors following intramuscular injection in patients.
To assess the safety profile of AAV integration by analyzing integration patterns in nuclear and mitochondrial genomes.

Main Methods:

Performed integration-site analysis after intramuscular injection of AAV1-LPL(S447X) in five lipoprotein lipase-deficient subjects.
Examined both nuclear and mitochondrial genomes for vector DNA integration.

Main Results:

Revealed random integration of AAV vectors within the nuclear genome.
Identified specific hotspots for AAV integration within the mitochondrial genome.
Observed vector breakage and integration occurring from various positions within the vector genome.

Conclusions:

AAV integration into host genomes, including mitochondria, appears potentially safe.
Future viral integration-site analyses should incorporate the mitochondrial genome for comprehensive assessment.